drugset / Trial / NCT02254824

Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients

NCT02254824

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of EMINENT study is to evaluate the efficacy of Xuezhikang or atorvastatin in hypertensive patients at low/moderate cardiovascular risk.

Timeline

Start
2013-10
Primary completion
2015-10
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule
Comparator Xuezhikang Traditional medicine (herbal / TCM)

Indications